The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis

BACKGROUND: Schizophrenia is a chronic and debilitating neuropsychiatric disorder that often requires long-term pharmacotherapy to manage symptoms and prevent relapse. Cariprazine is a potent dopamine D(3) and D(2) receptor partial agonist that is FDA-approved in the US for the treatment of schizoph...

詳細記述

保存先:
書誌詳細
出版年:BMC Psychiatry
主要な著者: Nasrallah, Henry A., Earley, Willie, Cutler, Andrew J., Wang, Yao, Lu, Kaifeng, Laszlovszky, István, Németh, György, Durgam, Suresh
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2017
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5571492/
https://ncbi.nlm.nih.gov/pubmed/28836957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-017-1459-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料